AbCellera Biologics (ABCL) Change in Accured Expenses (2024 - 2026)
AbCellera Biologics (ABCL) posted Change in Accured Expenses of -$9.4 million for Q1 2026, down 263.78% on a QoQ basis from $5.7 million in Q4 2025, and down 175.92% year-over-year from $12.4 million in Q1 2025.
AbCellera Biologics (ABCL) Change in Accured Expenses (2024 - 2026) Analysis & Trends
AbCellera Biologics' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at -$9.4 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 175.92% year-over-year to -$9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 120.98% YoY) and the FY2025 annual result came in at $3.5 million, down 67.49% from the prior year.
- Change in Accured Expenses was -$9.4 million for Q1 2026 at AbCellera Biologics, down from $5.7 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $6.6 million in Q4 2024 and bottomed at -$9.4 million in Q1 2026.
- A 3-year average of $520666.7 and a median of $4.1 million in 2024 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 30.11% in 2025, while the deepest fall reached 183.13% in 2025.
- AbCellera Biologics' Change in Accured Expenses stood at $6.6 million in 2024, then declined by 13.21% to $5.7 million in 2025, then slumped by 263.78% to -$9.4 million in 2026.
- Business Quant data shows ABCL's Change in Accured Expenses at -$9.4 million in Q1 2026, $5.7 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.41 Mn |
| Mar 31, 2026 | -9.41 Mn |
| Dec 31, 2025 | 5.74 Mn |
| Dec 31, 2025 | 5.74 Mn |
| Sep 30, 2025 | 5.07 Mn |
| Sep 30, 2025 | 5.07 Mn |
| Jun 30, 2025 | -3.95 Mn |
| Jun 30, 2025 | -3.95 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Dec 31, 2024 | 6.62 Mn |
| Dec 31, 2024 | 6.62 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Mar 31, 2024 | -4.88 Mn |